News at CenExel

Emraclidine, a novel positive allosteric modulator of cholinergic M4 receptors, for the treatment of schizophrenia: a two-part, randomised, double-blind, placebo-controlled, phase 1b trial

CenExel is proud to announce that the work of David Walling, PhD, CEO and Principal Investigator at CenExel CNS, joined lead author, John H Krystal,...

Primer on the Autonomic Nervous System – 4th Edition

Placebo-Control Reminder Script

General medicine studies are not immune to the placebo effect, where 30-40% of patients report improved subjective and objective outcomes in general medical studies (Hrobjartsson &...

Why Study Infant Formula?

JBR Clinical Research is currently seeking expectant mothers to participate in a clinical study to evaluate the safety and effectiveness of a low lactose infant...

Free Infant Formula Through JBR Clinical Research

JBR Clinical Research is conducting a clinical research study to evaluate growth and safety of a low-lactose milk-based infant formula. Participants must be healthy, term...

Tension Headache Study

Do you suffer from tension headaches? Signs and symptoms of a tension headache include: Dull, aching head pain The sensation of tightness or pressure across...

Thanks for a Great 2011!

Thanks for making 2011 a great year! Looking forward to a wonderful new year in 2012! Wishing you a Happy New Year! Your Friends at...

New Treatment in Trials for Psoriasis

Psoriasis is a skin condition that causes skin redness and irritation. Those with psoriasis have thick red skin with flaky, whit patches called scales. Psoriasis...

HPV Fast Facts

There are 4 types of HPV that cause most HPV diseases in women An estimated 8 out of 10 women will become infected in their...